赵晓光, 张艳珠. 替吉奥治疗老年进展期胃癌临床观察[J]. 实用临床医药杂志, 2011, (11): 103-105. DOI: 10.3969/j.issn.1672-2353.2011.11.036
引用本文: 赵晓光, 张艳珠. 替吉奥治疗老年进展期胃癌临床观察[J]. 实用临床医药杂志, 2011, (11): 103-105. DOI: 10.3969/j.issn.1672-2353.2011.11.036
ZHAO Xiao-guang, ZHANG Yan-zhu. Clinical investigation of S-1 alone in the treatment of elderly patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (11): 103-105. DOI: 10.3969/j.issn.1672-2353.2011.11.036
Citation: ZHAO Xiao-guang, ZHANG Yan-zhu. Clinical investigation of S-1 alone in the treatment of elderly patients with advanced gastric cancer[J]. Journal of Clinical Medicine in Practice, 2011, (11): 103-105. DOI: 10.3969/j.issn.1672-2353.2011.11.036

替吉奥治疗老年进展期胃癌临床观察

Clinical investigation of S-1 alone in the treatment of elderly patients with advanced gastric cancer

  • 摘要: 目的 观察替吉奥胶囊单药治疗老年进展期胃癌的临床疗效及不良反应.方法 33例老年进展期胃癌患者,应用替吉奥胶囊口服,至少完成2个周期后评价疗效和不良反应.结果 33例患者中完全缓解(CR) 1例(3%)、部分缓解(PR) 12例(36.4%)、稳定(SD) 6例(18.2%),总有效率RR39.4%,生活质量改善12例(36.4%),主要毒副反应为血液学毒性和消化道反应.结论 替吉奥胶囊是治疗进展期胃癌安全、有效的药物,特别适宜于老年体弱的患者.

     

/

返回文章
返回